Atlas Trials

Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2

Clinical trial NCT04479163 · COMPLETED

Trial details

NCT number
NCT04479163
Sponsor
Fundacion Infant
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
COVID
Start date
2020-06-04
Primary completion
2020-10-25
Enrollment
165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.